Adropin and Spexin Hormones Regulate the Systemic Inflammation in Adenine-Induced Chronic Kidney Failure in Rat
Authors:
- 1 July 2021
- journal article
- research article
- Published by Medknow in Chinese Journal of Physiology
- Vol. 64 (4) , 194-201
Abstract
Chronic kidney disease is one of the major global health problems. Chronic renal failure is stimulated by many cytokines and chemokines. Adropin and spexin (SPX) are peptides hormones. These peptides could affect inflammatory conditions, but this is unclear. Due to the limited information, we planned to investigate the impact of adropin and SPX hormones on systemic inflammation in adenine induced chronic kidney failure rat model. Chronic kidney failure was induced by administering adenine hemisulfate. Renal functions were measured by an autoanalyzer. Granulocyte colony-stimulating factor (G-CSF), interferon-gamma (IFN-γ), interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IL-17A, tumor necrosis factor-alpha, Eotaxin, growth-regulated oncogene-alpha, IP-10, monocyte chemoattractant protein (MCP)-1, MCP-3, macrophage inflammatory protein (MIP)-1α, MIP-2, and RANTES levels were determined by Luminex. We observed an increase in 24-h urine volume and serum creatinine. Blood urea nitrogen (BUN) and urine protein levels were also significantly higher in the chronic kidney failure (CKF) group. Urine protein and 24-h urine volume were reduced with adropin and SPX treatments. Furthermore, G-CSF, IFN-γ, IL-4, IL-5, IL-10, IL-12, IL-17A, and GRO-α significantly increased by CKF induction; however, these cytokines and chemokines significantly decreased by adropin treatment in the CKF group. Furthermore, adropin increased IP-10, MCP-1, MIP-1α, and MIP-2 levels. In addition, SPX treatment had a more limited effect, decreasing only G-CSF, IFN-γ, and IL-5 levels. The combined adropin + SPX treatment significantly reduced G-CSF, IFN-γ, IL-4, IL-5, IL-12, and IL-17A. Furthermore, IP-10, MCP-1, MCP-3, and MIP-2 were significantly increased by these combined treatments. Our findings indicate that renal functions and inflammatory response were modulated by adropin and SPX peptides. These peptides may have protective effects on systemic inflammation and renal failure progression.Keywords
This publication has 50 references indexed in Scilit:
- Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociceptionThe FASEB Journal, 2011
- Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular diseasePediatric Nephrology, 2009
- Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney diseaseClinical and Experimental Nephrology, 2009
- Evolutionary Sequence Modeling for Discovery of Peptide HormonesPLOS Computational Biology, 2009
- Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid MetabolismCell Metabolism, 2008
- TLR4 Signaling Mediates Inflammation and Tissue Injury in NephrotoxicityJournal of the American Society of Nephrology, 2008
- Identification of novel peptide hormones in the human proteome by hidden Markov model screeningGenome Research, 2007
- MCP-1 and RANTES Polymorphisms in Korean Diabetic End-Stage Renal DiseaseJournal of Korean Medical Science, 2007
- T Cells Are Necessary for Th2 Cytokine Production and Eosinophil Accumulation in Airways of Antigen-Challenged Allergic MiceClinical Immunology and Immunopathology, 1995
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989